Imatinib Supplier-Buyer Network — Trade Flow Analysis

Name: Imatinib Supplier-Buyer Trade Network Dataset — 224+ Indian Exporters, 23+ Importers, 119+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Imatinib supplier network, Imatinib buyers, pharmaceutical export India, Imatinib trade data

TransData Nexus

Imatinib

India Pharmaceutical Trade Intelligence

$29.3M224 Suppliers119 CountriesHS 30049049

ExportsIndia → UNITED STATES24.3%India → BELGIUM12.4%

ImportsGERMANY → India$331.7M UNITED STATES → India$584.7K

#1 Supplier: CIPLA LIMITED #1 Buyer: H.ESSERS &

Who Supplies Imatinib? Top Manufacturers & Buyers 2026 — CIPLA LIMITED Leads | TransData Nexus | TransData Nexus

1CIPLA LIMITED

CIPLA LIMITED is the first-largest Imatinib exporter from India, with a market share of 26.1% and a total export value of $7.6M across 103 shipments. Their average shipment value of $74.1K is above the market average of $17.0K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• H.ESSERS & ZONEN INTERNATIONAL TRAN — $3.3M across 45 shipments (43.4% of this supplier's total exports)

• HABIB BANK LIMITED — $1.3M across 17 shipments (16.9% of this supplier's total exports)

• JS BANK LTD. — $1.2M across 17 shipments (16.2% of this supplier's total exports)

• COOPER PHARMA — $942.6K across 13 shipments (12.3% of this supplier's total exports)

• MEDPRO PHARMACEUTICA (PTY) LTD — $857.1K across 12 shipments (11.2% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $74.1K is 337% above the market average of $17.0K, consistent with large-order contracts or value-added formulations.

2EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Imatinib exporter from India, with a market share of 13.8% and a total export value of $4.0M across 82 shipments. Their average shipment value of $49.2K is above the market average of $17.0K, suggesting premium or bulk contract pricing.

EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AUROBINDO PHARMA USA., INC — $1.5M across 31 shipments (38.1% of this supplier's total exports)

• AUROBINDO PHARMA USA., INC — $1.2M across 24 shipments (29.7% of this supplier's total exports)

• QUALLENT PHARMACEUTICALS HEALTH LLC — $553.2K across 11 shipments (13.7% of this supplier's total exports)

• AUROBINDO PHARMA USA., INC — $476.1K across 10 shipments (11.8% of this supplier's total exports)

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $272.3K across 6 shipments (6.8% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $49.2K is 190% above the market average of $17.0K, consistent with large-order contracts or value-added formulations.

3JODAS EXPOIM PRIVATE LIMITED

JODAS EXPOIM PRIVATE LIMITED is the third-largest Imatinib exporter from India, with a market share of 7.2% and a total export value of $2.1M across 38 shipments. Their average shipment value of $55.4K is above the market average of $17.0K, suggesting premium or bulk contract pricing.

JODAS EXPOIM PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• OOO"JODAS EXPOIM" — $1.0M across 19 shipments (49.2% of this supplier's total exports)

• OOO"JODAS EXPOIM" — $576.4K across 10 shipments (27.4% of this supplier's total exports)

• OOO"JODAS EXPOIM" — $428.0K across 8 shipments (20.3% of this supplier's total exports)

• SOFTCARE INTERNATION — $33.9K across 1 shipments (1.6% of this supplier's total exports)

• SOFTCARE INTERNATION — $30.8K across 1 shipments (1.5% of this supplier's total exports)

Key Insight: JODAS EXPOIM PRIVATE LIMITED's per-shipment value of $55.4K is 227% above the market average of $17.0K, consistent with large-order contracts or value-added formulations.

4SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fourth-largest Imatinib exporter from India, with a market share of 4.5% and a total export value of $1.3M across 72 shipments. Their average shipment value of $18.4K is above the market average of $17.0K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• SUN PHARMA ANZ PTY LTD. — $416.9K across 23 shipments (31.5% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES INC — $246.3K across 13 shipments (18.6% of this supplier's total exports)

• YUSEN LOGISTICS BENE — $238.0K across 13 shipments (18.0% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES INC — $233.5K across 13 shipments (17.6% of this supplier's total exports)

• SUN PHARMA PHILIPPINES INC. — $188.9K across 10 shipments (14.3% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $18.4K is 8% above the market average of $17.0K, consistent with large-order contracts or value-added formulations.

5INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the fifth-largest Imatinib exporter from India, with a market share of 2.8% and a total export value of $808.8K across 19 shipments. Their average shipment value of $42.6K is above the market average of $17.0K, suggesting premium or bulk contract pricing.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• XXCORXXHEAXXHCAXX SX — $255.9K across 6 shipments (31.6% of this supplier's total exports)

• ACCORD HEALTHCARE SLU — $255.7K across 6 shipments (31.6% of this supplier's total exports)

• XXCORXXHEAXXHCAXX PO — $141.9K across 3 shipments (17.5% of this supplier's total exports)

• XXCORXXHEAXXHCAXX LT — $77.9K across 2 shipments (9.6% of this supplier's total exports)

• ACCORD HEALTHCARE LI — $77.4K across 2 shipments (9.6% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $42.6K is 151% above the market average of $17.0K, consistent with large-order contracts or value-added formulations.

6NATCO PHARMA LIMITED

NATCO PHARMA LIMITED is the fifth-largest Imatinib exporter from India, with a market share of 1.6% and a total export value of $469.1K across 33 shipments. Their average shipment value of $14.2K is below the market average of $17.0K, reflecting a high-volume, competitive pricing strategy.

NATCO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• STADA ARZNEIMITTEL A — $156.9K across 11 shipments (33.5% of this supplier's total exports)

• ATLANTA MEDICARE CO — $85.9K across 6 shipments (18.3% of this supplier's total exports)

• NATCO PHARMA (CANADA — $80.4K across 6 shipments (17.1% of this supplier's total exports)

• ATLANTA MEDICARE CO — $74.4K across 5 shipments (15.9% of this supplier's total exports)

• MEDIS INTERNATIONAL — $71.4K across 5 shipments (15.2% of this supplier's total exports)

Key Insight: NATCO PHARMA LIMITED operates with high shipment frequency (33 shipments) at a per-shipment value of $14.2K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Imatinib imports from India, with a total trade value of $7.1M across 100 shipments — representing a 24.3% share of all Imatinib exports. The average shipment value of $71.1K is above the global average of $17.0K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.

Named Imatinib importers in United States: AUROLOGISTICS LLC, (AUROBINDO PHARM is the largest buyer, accounting for 25.2% ($1.8M) of this market's total imports.

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $1.8M (25.2% of United States's total)

• AUROBINDO PHARMA USA INC — $1.5M (21.6% of United States's total)

• AUROBINDO PHARMA USA., INC, — $1.2M (16.8% of United States's total)

Key Insight: United States's per-shipment average of $71.1K (319% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Imatinib imports from India.

Primary Market

Secondary Market

2Belgium

Belgium ranks as the second-largest destination for Imatinib imports from India, with a total trade value of $3.6M across 6 shipments — representing a 12.4% share of all Imatinib exports. The average shipment value of $607.3K is above the global average of $17.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Imatinib importers in Belgium: H.ESSERS & ZONEN INTERNATIONAL TRAN is the largest buyer, accounting for 91.6% ($3.3M) of this market's total imports.

• H.ESSERS & ZONEN INTERNATIONAL TRAN — $3.3M (91.6% of Belgium's total)

Key Insight: Belgium's per-shipment average of $607.3K (3479% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Imatinib imports from India.

Primary Market

Secondary Market

3Pakistan

Pakistan ranks as the third-largest destination for Imatinib imports from India, with a total trade value of $3.2M across 32 shipments — representing a 11.1% share of all Imatinib exports. The average shipment value of $101.4K is above the global average of $17.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Imatinib importers in Pakistan: HABIB BANK LIMITED is the largest buyer, accounting for 39.7% ($1.3M) of this market's total imports.

• HABIB BANK LIMITED — $1.3M (39.7% of Pakistan's total)

• JS BANK LTD. — $1.2M (38.0% of Pakistan's total)

Key Insight: Pakistan's per-shipment average of $101.4K (498% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Pakistan is a key market for Imatinib imports from India.

Primary Market

Secondary Market

4Russia

Russia ranks as the fourth-largest destination for Imatinib imports from India, with a total trade value of $2.7M across 24 shipments — representing a 9.1% share of all Imatinib exports. The average shipment value of $111.2K is above the global average of $17.0K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Imatinib importers in Russia: OOO"JODAS EXPOIM" is the largest buyer, accounting for 50.6% ($1.4M) of this market's total imports.

• OOO"JODAS EXPOIM" — $1.4M (50.6% of Russia's total)

• OOO JODAS EXPOIM — $690.4K (25.9% of Russia's total)

• OOOJODAS EXPOIM — $576.4K (21.6% of Russia's total)

Key Insight: Russia's per-shipment average of $111.2K (556% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Russia is a key market for Imatinib imports from India.

Primary Market

Secondary Market

5Morocco

Morocco ranks as the fifth-largest destination for Imatinib imports from India, with a total trade value of $2.4M across 16 shipments — representing a 8.2% share of all Imatinib exports. The average shipment value of $150.7K is above the global average of $17.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Imatinib importers in Morocco: COOPER PHARMA is the largest buyer, accounting for 78.0% ($1.9M) of this market's total imports.

• COOPER PHARMA — $1.9M (78.0% of Morocco's total)

Key Insight: Morocco's per-shipment average of $150.7K (788% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Morocco is a key market for Imatinib imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Imatinib.
2.Flow Mapping: 224 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,726 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 119 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,726 Verified Shipments

224 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Imatinib

Imatinib

Who Supplies Imatinib? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Imatinib? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Imatinib Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1CIPLA LIMITED

2EUGIA PHARMA SPECIALITIES LIMITED

3JODAS EXPOIM PRIVATE LIMITED

4SUN PHARMACEUTICAL INDUSTRIES LIMITED

5INTAS PHARMACEUTICALS LIMITED

6NATCO PHARMA LIMITED

From Indian Factories to Global Pharmacies — How Imatinib Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Imatinib Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Belgium

3Pakistan

4Russia

5Morocco

People Also Ask — Imatinib Supplier & Trade Network

Imatinib Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology